This comprehensive guide explores the critical decision between High-Performance Liquid Chromatography (HPLC) and Ultra-Performance Liquid Chromatography (UPLC) for resolving complex drug mixtures in pharmaceutical research and development.
This comprehensive article addresses the critical role of High-Performance Liquid Chromatography (HPLC) in the therapeutic drug monitoring (TDM) of anticonvulsant medications.
This definitive guide for chromatographers addresses the critical challenge of peak broadening in HPLC and UPLC.
This comprehensive guide provides researchers, scientists, and drug development professionals with a detailed roadmap for validating HPLC and UPLC methods in accordance with the latest ICH Q2(R2) guideline.
This comprehensive guide explores the fundamental and practical distinctions between HPLC and UPLC, with a focus on the critical relationship between stationary phase particle size and system pressure.
This article provides a detailed, practical guide for researchers and scientists on correlating HPLC and UPLC methods for vancomycin therapeutic drug monitoring (TDM).
This article provides a comprehensive comparison of Hydrophilic Interaction Liquid Chromatography (HILIC) and Reversed-Phase Liquid Chromatography (RPLC) coupled with tandem mass spectrometry (MS/MS) for the targeted analysis of polar metabolites.
This article provides a comprehensive framework for applying Gaussian Processes (GPs) to estimate uncertainty in biomarker response data, a critical challenge in modern drug development.
This article provides a comprehensive overview of Gaussian Process (GP) regression for quantifying and modeling uncertainty in dose-response relationships.
This article provides a comprehensive comparison between traditional IC50 values and the more recent Growth Rate Inhibition (GR) metrics for quantifying drug response in pre-clinical research.